TEVA logo

TEVA Selling, general & administrative expenses

annual SGA:

$3.70B+$204.00M(+5.83%)
December 31, 2024

Summary

  • As of today (May 29, 2025), TEVA annual SGA is $3.70 billion, with the most recent change of +$204.00 million (+5.83%) on December 31, 2024.
  • During the last 3 years, TEVA annual SGA has risen by +$174.00 million (+4.93%).
  • TEVA annual SGA is now -30.40% below its all-time high of $5.32 billion, reached on December 31, 2013.

Performance

TEVA SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

quarterly SGA:

$919.00M-$33.00M(-3.47%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TEVA quarterly SGA is $919.00 million, with the most recent change of -$33.00 million (-3.47%) on March 31, 2025.
  • Over the past year, TEVA quarterly SGA has increased by +$33.00 million (+3.72%).
  • TEVA quarterly SGA is now -36.53% below its all-time high of $1.45 billion, reached on December 31, 2013.

Performance

TEVA quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

TTM SGA:

-$59.61B-$1.28B(-2.20%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TEVA TTM SGA is -$59.61 billion, with the most recent change of -$1.28 billion (-2.20%) on March 31, 2025.
  • Over the past year, TEVA TTM SGA has dropped by -$63.15 billion (-1782.83%).
  • TEVA TTM SGA is now -199.44% below its all-time high of $59.94 billion.

Performance

TEVA TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

TEVA Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.8%+3.7%-1782.8%
3 y3 years+4.9%+4.4%-1787.1%
5 y5 years-2.7%+0.2%-1675.2%

TEVA Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7.5%-3.5%+11.8%-38.5%at low
5 y5-year-2.7%+7.5%-9.0%+11.8%-115.5%at low
alltimeall time-30.4%>+9999.0%-36.5%+1863.7%-199.4%at low

TEVA Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$919.00M(-3.5%)
$3.73B(+0.9%)
Dec 2024
$3.70B(+5.8%)
$952.00M(+3.0%)
$3.70B(+1.4%)
Sep 2024
-
$924.00M(-1.6%)
$3.65B(+2.2%)
Jun 2024
-
$939.00M(+6.0%)
$3.57B(+0.8%)
Mar 2024
-
$886.00M(-1.8%)
$3.54B(+1.3%)
Dec 2023
$3.50B(+1.5%)
$902.00M(+6.9%)
$3.50B(+1.9%)
Sep 2023
-
$844.00M(-7.3%)
$3.43B(+0.6%)
Jun 2023
-
$910.00M(+8.1%)
$3.41B(+0.1%)
Mar 2023
-
$842.00M(+0.6%)
$3.41B(-1.1%)
Dec 2022
$3.44B(-2.4%)
$837.00M(+1.8%)
$3.45B(-2.0%)
Sep 2022
-
$822.00M(-9.4%)
$3.52B(-1.8%)
Jun 2022
-
$907.00M(+3.1%)
$3.58B(+1.4%)
Mar 2022
-
$880.00M(-3.1%)
$3.53B(+0.1%)
Dec 2021
$3.53B(-3.9%)
$908.00M(+2.3%)
$3.53B(-2.8%)
Sep 2021
-
$888.00M(+3.6%)
$3.63B(+0.1%)
Jun 2021
-
$857.00M(-2.1%)
$3.63B(-0.1%)
Mar 2021
-
$875.00M(-13.4%)
$3.63B(-1.1%)
Dec 2020
$3.67B(-3.5%)
$1.01B(+14.3%)
$3.67B(-0.4%)
Sep 2020
-
$884.00M(+2.7%)
$3.69B(+0.1%)
Jun 2020
-
$861.00M(-6.1%)
$3.68B(-2.7%)
Mar 2020
-
$917.00M(-10.5%)
$3.78B(-0.6%)
Dec 2019
$3.81B(-9.7%)
$1.02B(+16.5%)
$3.81B(-3.0%)
Sep 2019
-
$880.00M(-8.5%)
$3.92B(-3.2%)
Jun 2019
-
$962.00M(+2.3%)
$4.05B(-0.9%)
Mar 2019
-
$940.00M(-17.6%)
$4.09B(-3.0%)
Dec 2018
$4.21B(-13.0%)
$1.14B(+13.2%)
$4.21B(+3.5%)
Sep 2018
-
$1.01B(+1.0%)
$4.07B(-4.8%)
Jun 2018
-
$998.00M(-6.5%)
$4.28B(-6.7%)
Mar 2018
-
$1.07B(+6.7%)
$4.59B(-5.3%)
Dec 2017
$4.85B(-2.6%)
$1.00B(-17.7%)
$4.85B(-6.1%)
Sep 2017
-
$1.22B(-7.0%)
$5.16B(-0.7%)
Jun 2017
-
$1.31B(-1.3%)
$5.20B(+0.9%)
Mar 2017
-
$1.32B(+0.5%)
$5.15B(+3.6%)
Dec 2016
$4.97B(+2.8%)
$1.32B(+5.4%)
$4.97B(-0.2%)
Sep 2016
-
$1.25B(-1.0%)
$4.98B(+3.2%)
Jun 2016
-
$1.26B(+10.5%)
$4.83B(+1.6%)
Mar 2016
-
$1.14B(-13.9%)
$4.75B(-1.8%)
Dec 2015
$4.84B(-4.7%)
$1.33B(+21.2%)
$4.84B(+0.0%)
Sep 2015
-
$1.10B(-7.5%)
$4.84B(-3.0%)
Jun 2015
-
$1.19B(-3.6%)
$4.98B(-0.8%)
Mar 2015
-
$1.23B(-7.3%)
$5.02B(-1.1%)
Dec 2014
$5.08B(-4.5%)
$1.33B(+6.7%)
$5.08B(-2.3%)
Sep 2014
-
$1.24B(+1.6%)
$5.20B(-0.5%)
Jun 2014
-
$1.22B(-4.9%)
$5.22B(-1.5%)
Mar 2014
-
$1.29B(-11.2%)
$5.30B(-0.3%)
Dec 2013
$5.32B(+3.9%)
$1.45B(+14.2%)
$5.32B(+1.4%)
Sep 2013
-
$1.27B(-2.5%)
$5.25B(+1.2%)
Jun 2013
-
$1.30B(-0.1%)
$5.18B(+0.1%)
Mar 2013
-
$1.30B(-5.2%)
$5.18B(+1.2%)
Dec 2012
$5.12B(+16.0%)
$1.37B(+13.9%)
$5.12B(+0.5%)
Sep 2012
-
$1.21B(-7.0%)
$5.09B(+6.0%)
Jun 2012
-
$1.30B(+4.6%)
$4.81B(+4.5%)
Mar 2012
-
$1.24B(-8.2%)
$4.60B(+4.2%)
Dec 2011
$4.41B(+15.1%)
$1.35B(+47.2%)
$4.41B(+6.6%)
Sep 2011
-
$918.00M(-15.6%)
$4.14B(-1.6%)
Jun 2011
-
$1.09B(+3.3%)
$4.21B(+6.5%)
Mar 2011
-
$1.05B(-2.4%)
$3.95B(+3.1%)
Dec 2010
$3.83B
$1.08B(+9.3%)
$3.83B(+2.9%)
Sep 2010
-
$987.00M(+18.5%)
$3.72B(+2.9%)
Jun 2010
-
$833.00M(-10.8%)
$3.62B(-0.4%)
DateAnnualQuarterlyTTM
Mar 2010
-
$934.00M(-3.7%)
$3.63B(+3.8%)
Dec 2009
$3.50B(+39.3%)
$970.00M(+9.9%)
$3.50B(+9.0%)
Sep 2009
-
$883.00M(+4.4%)
$3.21B(+7.9%)
Jun 2009
-
$846.00M(+5.8%)
$2.97B(+6.3%)
Mar 2009
-
$800.00M(+17.6%)
$2.80B(+11.4%)
Dec 2008
$2.51B(+32.1%)
$680.00M(+4.9%)
$2.51B(+6.9%)
Sep 2008
-
$648.00M(-3.1%)
$2.35B(+8.8%)
Jun 2008
-
$669.00M(+30.2%)
$2.16B(+10.2%)
Mar 2008
-
$514.00M(-0.8%)
$1.96B(+3.1%)
Dec 2007
$1.90B(+20.9%)
$518.00M(+13.1%)
$1.90B(+2.2%)
Sep 2007
-
$458.00M(-2.3%)
$1.86B(+3.0%)
Jun 2007
-
$469.00M(+2.9%)
$1.81B(+5.5%)
Mar 2007
-
$456.00M(-4.4%)
$1.71B(+8.9%)
Dec 2006
$1.57B(+96.7%)
$477.10M(+18.2%)
$1.57B(+19.8%)
Sep 2006
-
$403.80M(+7.5%)
$1.31B(+16.9%)
Jun 2006
-
$375.50M(+18.8%)
$1.12B(+20.7%)
Mar 2006
-
$316.00M(+45.2%)
$930.40M(+16.4%)
Dec 2005
$799.00M(+14.6%)
$217.70M(+1.7%)
$799.00M(+3.8%)
Sep 2005
-
$214.00M(+17.1%)
$769.70M(+4.4%)
Jun 2005
-
$182.70M(-1.0%)
$737.20M(+1.9%)
Mar 2005
-
$184.60M(-2.0%)
$723.50M(+3.8%)
Dec 2004
$697.00M(+33.9%)
$188.40M(+3.8%)
$697.00M(+7.0%)
Sep 2004
-
$181.50M(+7.4%)
$651.30M(+9.4%)
Jun 2004
-
$169.00M(+6.9%)
$595.10M(+7.0%)
Mar 2004
-
$158.10M(+10.8%)
$556.00M(+6.8%)
Dec 2003
$520.60M(+28.1%)
$142.70M(+13.9%)
$520.60M(+8.0%)
Sep 2003
-
$125.30M(-3.5%)
$482.00M(+3.6%)
Jun 2003
-
$129.90M(+5.9%)
$465.10M(+7.2%)
Mar 2003
-
$122.70M(+17.9%)
$433.90M(+6.8%)
Dec 2002
$406.40M(+11.8%)
$104.10M(-4.0%)
$406.40M(+1.4%)
Sep 2002
-
$108.40M(+9.8%)
$400.86M(+6.4%)
Jun 2002
-
$98.70M(+3.7%)
$376.66M(+2.1%)
Mar 2002
-
$95.20M(-3.4%)
$368.74M(+1.4%)
Dec 2001
$363.56M(+18.4%)
$98.56M(+17.1%)
$363.60M(+1.3%)
Sep 2001
-
$84.20M(-7.2%)
$359.04M(+1.7%)
Jun 2001
-
$90.78M(+0.8%)
$353.11M(+5.3%)
Mar 2001
-
$90.06M(-4.2%)
$335.48M(+9.2%)
Dec 2000
$307.08M(+31.3%)
$94.00M(+20.1%)
$307.08M(+8.8%)
Sep 2000
-
$78.27M(+7.0%)
$282.27M(+8.1%)
Jun 2000
-
$73.14M(+18.6%)
$261.20M(+7.6%)
Mar 2000
-
$61.66M(-10.9%)
$242.85M(+3.8%)
Dec 1999
$233.89M(+12.4%)
$69.19M(+21.0%)
$233.89M(+6.4%)
Sep 1999
-
$57.20M(+4.4%)
$219.80M(-0.0%)
Jun 1999
-
$54.80M(+4.0%)
$219.90M(+2.8%)
Mar 1999
-
$52.70M(-4.4%)
$214.00M(+2.8%)
Dec 1998
$208.00M(+5.6%)
$55.10M(-3.8%)
$208.10M(+36.0%)
Sep 1998
-
$57.30M(+17.2%)
$153.00M(+59.9%)
Jun 1998
-
$48.90M(+4.5%)
$95.70M(+104.5%)
Mar 1998
-
$46.80M
$46.80M
Dec 1997
$197.00M(+17.5%)
-
-
Dec 1996
$167.60M(+15.3%)
-
-
Dec 1995
$145.40M(+12.1%)
-
-
Dec 1994
$129.70M(+28.2%)
-
-
Dec 1993
$101.20M(+22.7%)
-
-
Dec 1992
$82.50M(+23.0%)
-
-
Dec 1991
$67.10M(-20.9%)
-
-
Dec 1990
$84.80M(+51.2%)
-
-
Dec 1989
$56.10M(+9.4%)
-
-
Dec 1988
$51.30M(+69.3%)
-
-
Mar 1987
$30.30M(+78.2%)
-
-
Mar 1986
$17.00M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual SGA?
  • What is the all time high annual SGA for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual SGA year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly SGA?
  • What is the all time high quarterly SGA for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly SGA year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM SGA?
  • What is the all time high TTM SGA for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM SGA year-on-year change?

What is Teva Pharmaceutical Industries Limited annual SGA?

The current annual SGA of TEVA is $3.70B

What is the all time high annual SGA for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual SGA is $5.32B

What is Teva Pharmaceutical Industries Limited annual SGA year-on-year change?

Over the past year, TEVA annual SGA has changed by +$204.00M (+5.83%)

What is Teva Pharmaceutical Industries Limited quarterly SGA?

The current quarterly SGA of TEVA is $919.00M

What is the all time high quarterly SGA for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly SGA is $1.45B

What is Teva Pharmaceutical Industries Limited quarterly SGA year-on-year change?

Over the past year, TEVA quarterly SGA has changed by +$33.00M (+3.72%)

What is Teva Pharmaceutical Industries Limited TTM SGA?

The current TTM SGA of TEVA is -$59.61B

What is the all time high TTM SGA for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM SGA is $59.94B

What is Teva Pharmaceutical Industries Limited TTM SGA year-on-year change?

Over the past year, TEVA TTM SGA has changed by -$63.15B (-1782.83%)
On this page